000 | 01209 a2200325 4500 | ||
---|---|---|---|
005 | 20250515062540.0 | ||
264 | 0 | _c20070622 | |
008 | 200706s 0 0 eng d | ||
022 | _a1462-8902 | ||
024 | 7 |
_a10.1111/j.1463-1326.2006.00665.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHermansen, K | |
245 | 0 | 0 |
_aDoes insulin detemir have a role in reducing risk of insulin-associated weight gain? _h[electronic resource] |
260 |
_bDiabetes, obesity & metabolism _cMay 2007 |
||
300 |
_a209-17 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aBlood Glucose _xanalysis |
650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
650 | 0 | 4 |
_aInsulin _xadverse effects |
650 | 0 | 4 | _aInsulin Detemir |
650 | 0 | 4 | _aInsulin, Long-Acting |
650 | 0 | 4 |
_aWeight Gain _xdrug effects |
700 | 1 | _aDavies, M | |
773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 9 _gno. 3 _gp. 209-17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1463-1326.2006.00665.x _zAvailable from publisher's website |
999 |
_c16945202 _d16945202 |